A Doctor’s Perspective on Rx Drug Access and Affordability
For me, one of the most fulfilling aspects of the practice of medicine is knowing I’ve helped patients make decisions that support their long-term health and longevity.
Pharmacy
Contract Pharmacal Corp. acquires Florida Pharmaceutical Products
Contract Pharmacal Corp. (CPC) recently acquired Florida Pharmaceutical Products (FPP), a generic pharmaceutical company focused on R&D, co-development and licensing. Headed by its president, 35-year industry veteran Larry Lapila, FPP has already inked a variety of partnership agreements in 2019.
HDA honors manufacturers with 2019 DIANA Awards
The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA).
Novartis and Sandoz honored with Power of Partnership Award
STAMFORD, Conn. – Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Novartis and its Sandoz division, in recognition of their outstanding commitment to increasing access to health care around the world.
John Gray announces retirement from HDA
John Gray, president and chief executive officer of the Healthcare Distribution Alliance (HDA), announced on Monday his retirement from the organization. Gray will remain in his position until May 2, 2020.
Community pharmacies play a critical role in health care
Community pharmacies are a pillar of neighborhoods today. The pharmacists in these pharmacies play a critical role in delivering health care to patients in their communities, as they have many more touchpoints with patients than insurance plans or other health care providers.
Lilly helping people prepare for disasters, making meds available
The 2019 Atlantic hurricane season begins June 1. With natural disasters and extreme weather on the rise, it’s critical to be prepared and ready to respond. That’s why Eli Lilly and Co.
Gilead Sciences names Mercier as CCO
Gilead Sciences announced that Johanna Mercier will join the company as chief commercial officer, and will become a member of the company’s senior leadership team. Mercier will assume responsibility for the company’s commercial operations effective July 1.
DIR relief urgency inspires over 4,700 letters to Congress
Already over the past week, NACDS RxIMPACT grassroots advocates have sent more than 4,700 letters to Congress. Their case is crucial: DIR relief is needed now for pharmacies’ viability and to reduce out-of-pocket drug costs for patients.
NACDS expands recommendations for opioid abuse prevention
ALEXANDRIA, Va. – The National Association of Chain Drug Stores (NACDS) has announced four more policy recommendations for opioid abuse prevention. The new proposals build on current policies backed by NACDS, which are achieving results at the federal and state levels.
Cancer mortality continues to decline
The latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decline in men, women, and children in the United States from 1999 to 2016. Overall cancer incidence rates, or rates of new cancers, decreased in men from 2008 to
Cardinal Health releases fifth edition of Oncology Insights
Oncologists said they see a growing role for artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research from Cardinal Health Specialty Solutions.
Sen. Wyden visits NCPA board member’s community pharmacy
Sen. Ron Wyden (D, Ore.), ranking member of the Senate Finance Committee, this week visited Grants Pass Pharmacy in Grants Pass, Ore.
Pharmacy “DIR fee” loophole must close, NACDS RxIMPACT urges
The National Association of Chain Drug Stores (NACDS) RxIMPACT program has launched an Action Alert, urging Congress to provide “DIR fee” relief in time to save pharmacies and to reduce seniors’ out-of-pocket drug costs. Through NACDS RxIMPACT, pharmacy advocates are contacting U.S.